Kenya - English - Pharmacy and Poisons Board

ajanta pharma limited ajanta pharma limited ajanta house, charkop, - bepotastine besilate - ophthalmic solution - bepotastine besilate 1.5% w/v

Kenya - English - Pharmacy and Poisons Board

ajanta pharma limited ajanta pharma limited ajanta house, charkop, - ofloxacin usp - film-coated tablet - each film coated tablet contains: ofloxacin usp… - ofloxacin

Kenya - English - Pharmacy and Poisons Board

ajanta pharma limited ajanta pharma limited, ajanta house, charkop, - aceclofenac bp and paracetamol bp - film-coated tablet - aceclofenac bp 100mg paracetamol bp 500mg - non-steroidal

Kenya - English - Pharmacy and Poisons Board

ajanta pharma limited. ajanta pharma limited. - sitagliptin phosphate monohydrate usp - tablet - each film coated tablet contains: sitagliptin… - sitagliptin

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

ajanta pharma limited, india - artemether & lumefantrine tablets - uncoated tablets - 60/360

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

ajanta pharma limited, india - artemether & lumefantrine tablets - uncoated tablets - 80/480

Ireland - English - HPRA (Health Products Regulatory Authority)

ajanta pharma uk limited - sildenafil citrate - film coated tablet - 50 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ajanta pharma uk limited - sildenafil citrate - film coated tablet - 100 milligram

United States - English - NLM (National Library of Medicine)

ajanta pharma limited - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 250 mg - levetiracetam tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. levetiracetam tablets are indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam tablets are indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. levetiracetam tablets are contraindicated in patients with a hypersensitivity to levetiracetam. reactions have included anaphylaxis and angioedema [see warnings and precautions (5.4)] . levetiracetam blood levels may decrease during pregnancy [see warnings and precautions (5.10) ]. pregnancy category c there are no adequate and controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of developmental toxicity, including teratogen

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

ajanta pharma limited, india - sitagliptin phosphate monohydrate - film coated tablet - 100